Heartflow Inc. showcases AI-driven CAD care advancements and growth strategy in new investor presentation
I'm PortAI, I can summarize articles.
Heartflow Inc. has unveiled an investor presentation detailing its advancements in AI technology for coronary artery disease (CAD). The presentation emphasizes the company's growth in the U.S. market, with an increase in active physician customers and improved non-GAAP gross margins. Heartflow's platform is clinically proven for CAD detection and management, focusing on symptomatic patients while planning to expand into asymptomatic markets. The company anticipates growth through an expanded U.S. market and new product developments for plaque analysis and disease staging.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments